SMED
Get informed when a big investor buys or sells
+ FollowUndervalued by 18.6% based on the discounted cash flow analysis.
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-5,539,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.76 |
| Beta | 1.28 |
| Outstanding Shares | 19,412,000 |
| P/E Ratio | 11.58 |
|---|---|
| PEG | -11.27 |
| Price to Sales | 2.92 |
| Price to Book Ratio | 2.92 |
| Enterprise Value to Revenue | -0.08 |
| Enterprise Value to EBIT | -1.05 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -3.83 |
| Debt to Equity | 0.33 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data